| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 458.963 | 91 |
| GSM780708 | Untreated after 4 days (C2_1) | 466.478 | 91 |
| GSM780709 | Untreated after 4 days (C3_1) | 453.31 | 91 |
| GSM780719 | Untreated after 4 days (C1_2) | 516.022 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 489.939 | 91 |
| GSM780721 | Untreated after 4 days (C3_2) | 482.804 | 91 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 408.186 | 90 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 494.362 | 91 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 425.386 | 90 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 412.865 | 90 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 526.56 | 92 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 469.038 | 91 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 513.729 | 92 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 448.803 | 91 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 498.045 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 507.682 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 486.821 | 91 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 517.322 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 503.757 | 92 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 486.679 | 91 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 426.568 | 90 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 491.094 | 91 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 468.637 | 91 |